GALECTIN THERAPEUTICS INC. (GALT) Operating income 2016–2025
GALECTIN THERAPEUTICS INC. (GALT) annual operating income history from SEC filings — each fiscal year as reported.
-$20.1MFY2025 · since FY2016: -$21.5M → -$20.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.1M | +52.7% |
| FY2024 | -$42.4M | -11.5% |
| FY2023 | -$38.1M | +0.7% |
| FY2022 | -$38.4M | -27.1% |
| FY2021 | -$30.2M | -28.7% |
| FY2020 | -$23.4M | -74.5% |
| FY2019 | -$13.4M | +1.2% |
| FY2018 | -$13.6M | +16.3% |
| FY2017 | -$16.2M | +24.4% |
| FY2016 | -$21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice